Effects of Telbivudine Treatment on the Circulating CD4+ T-Cell Subpopulations in Chronic Hepatitis B Patients

• Egile Nagusiak: Yanhua Zheng (Egilea), Zemin Huang (Egilea), Xianhua Chen (Egilea), Yi Tian (Egilea), Jun Tang (Egilea), Yi Zhang (Egilea), Xiaomin Zhang (Egilea), Jijun Zhou (Egilea), Qing Mao (Egilea), Bing Ni (Egilea), Qinghong Wang (Egilea), Yuzhang Wu (Egilea)
• Formatua: Liburua
• Argitaratua: Hindawi Limited, 2012-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

CD4+ T cells serve as master regulators of the adaptive immune response to HBV. However, CD4+ T-cell subsets are heterogeneous, and it remains unknown how the antiviral agents affect the different CD4+ T cell subtypes. To this end, the expressions of signature transcription factors and cytokines of...